Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

China flag China · Delayed Price · Currency is CNY
3.600
-0.030 (-0.83%)
Mar 10, 2026, 2:04 PM CST
1.41%
Market Cap 9.14B
Revenue (ttm) 15.94B
Net Income (ttm) 449.15M
Shares Out 2.52B
EPS (ttm) 0.18
PE Ratio 20.25
Forward PE 13.96
Dividend n/a
Ex-Dividend Date n/a
Volume 36,188,955
Average Volume 26,969,498
Open 3.630
Previous Close 3.630
Day's Range 3.580 - 3.640
52-Week Range 3.060 - 4.150
Beta 0.21
RSI 63.50
Earnings Date Apr 23, 2026

About SHA:600664

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese medicines, and antibiotics. It also provides calcium ... [Read more]

Sector Healthcare
Founded 1991
Employees 10,180
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600664
Full Company Profile

Financial Performance

In 2024, SHA:600664's revenue was 16.18 billion, an increase of 4.65% compared to the previous year's 15.46 billion. Earnings were 628.85 million, an increase of 59.10%.

Financial Statements

News

There is no news available yet.